Skip to main content
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1973 Jun;36(3):399–410. doi: 10.1136/jnnp.36.3.399

Possible neurogenic factor in muscular dystrophy: its similarity to denervation atrophy1

Darab K Dastur 1,2, Zohra A Razzak 1,2
PMCID: PMC494339  PMID: 4714102

Abstract

Muscle biopsy specimens from 179 cases of muscular dystrophies and from 140 cases of anterior horn cell disorders (from a total of 1,348 biopsied patients) were examined histologically. There were 72 cases of Duchenne type muscular dystrophy (DMD), five of Becker type MD, four girls with myopathy resembling DMD, 40 with limb-girdle, 10 with facioscapulohumeral, seven with late onset, 13 with congenital, and 28 with unclassifiable muscular dystrophies. Groups of small atrophied muscle fibres were encountered in 42 (23%) of the cases in this group, most frequently in patients with limb-girdle, facioscapulohumeral, and least frequently with DM dystrophy. In the second group there were 25 cases of infantile, 38 of juvenile, and 39 of adult spinal muscular atrophy (SMA); there were 21 patients with motor neurone disease (MND), six with poliomyelitis, and 11 with an unclassifiable type of anterior horn cell disorder. Pseudomyopathic changes were encountered in 43 (30%) of all cases in this group. They were most frequently present among patients with juvenile and adult SMA and in those with MND. The presence of group atrophy in muscular dystrophy is considered significant myopathological evidence of a denervation process. On the other hand, pseudomyopathic changes, variation in fibre size, rounding, central nuclei, and increase in connective tissue occurring in various anterior horn cell disorders are seen not to be specific `myopathic' changes. Thus there was an overlap of pathological reactions in muscles from the dystrophies and the neurogenic atrophies. Comparably atrophied fibres (much less than 2 SDs below the normal mean diameter) and hypertrophied fibres (much more than 2 SDs above the normal mean diameter) were encountered in both dystrophy and neurogenic atrophy, considering the large muscles of the limb. Likewise, the mean fibre diameters were comparable in DMD and in juvenile SMA. The fourth evidence of a neurogenic factor in muscular dystrophy was derived from an examination of SDH preparations of muscle. There was a preponderance of type I muscle fibres in dystrophic muscles compared with specimens from controls, suggesting depletion of type II fibres. It appears that the concept of muscular dystrophy as a primary muscle disease needs to be re-examined.

Full text

PDF
399

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BYERS R. K., BANKER B. Q. Infantile muscular atrophy. Arch Neurol. 1961 Aug;5:140–164. doi: 10.1001/archneur.1961.00450140022003. [DOI] [PubMed] [Google Scholar]
  2. Bell C. D., Conen P. E. Change in fiber size in Duchenne muscular dystrophy. Neurology. 1967 Sep;17(9):902–913. doi: 10.1212/wnl.17.9.902. [DOI] [PubMed] [Google Scholar]
  3. Brooke M. H., Engel W. K. The histographic analysis of human muscle biopsies with regard to fiber types. 1. Adult male and female. Neurology. 1969 Mar;19(3):221–233. doi: 10.1212/wnl.19.3.221. [DOI] [PubMed] [Google Scholar]
  4. Caspary E. A., Currie S., Field E. J. Sensitized lymphocytes in muscular dystrophy: evidence for a neural factor in pathogenesis. J Neurol Neurosurg Psychiatry. 1971 Jun;34(3):353–356. doi: 10.1136/jnnp.34.3.353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cohen H. J., Molnar G. E., Taft L. T. The genetic relationship of progressive muscular dystrophy (Duchenne type) and mental retardation. Dev Med Child Neurol. 1968 Dec;10(6):754–765. doi: 10.1111/j.1469-8749.1968.tb02974.x. [DOI] [PubMed] [Google Scholar]
  6. Dastur D. K. Muscle disorders. A study in histological reactions. Indian J Pathol Bacteriol. 1967 Apr;10(2):184–192. [PubMed] [Google Scholar]
  7. Dastur D. K., Razzak Z. A., Bharucha E. P. Arthrogryposis multiplex congenita. 2. Muscle pathology and pathogenesis. J Neurol Neurosurg Psychiatry. 1972 Aug;35(4):435–450. doi: 10.1136/jnnp.35.4.435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Drachman D. B., Murphy S. R., Nigam M. P., Hills J. R. "Myopathic" changes in chronically denervated muscle. Arch Neurol. 1967 Jan;16(1):14–24. doi: 10.1001/archneur.1967.00470190018002. [DOI] [PubMed] [Google Scholar]
  9. Engel W. K. Selective and nonselective susceptibility of muscle fiber types. A new approach to human neuromuscular diseases. Arch Neurol. 1970 Feb;22(2):97–117. doi: 10.1001/archneur.1970.00480200003001. [DOI] [PubMed] [Google Scholar]
  10. HUGHES B. P. A method for the estimation of serum creatine kinase and its use in comparing creatine kinase and aldolase activity in normal and pathological sera. Clin Chim Acta. 1962 Sep;7:597–603. doi: 10.1016/0009-8981(62)90137-7. [DOI] [PubMed] [Google Scholar]
  11. Hathaway P. W., Engel W. K., Zellweger H. Experimental myopathy after microarterial embolization; comparison with childhood x-linked pseudohypertrophic muscular dystrophy. Arch Neurol. 1970 Apr;22(4):365–378. doi: 10.1001/archneur.1970.00480220079011. [DOI] [PubMed] [Google Scholar]
  12. KUGELBERG E., WELANDER L. Heredofamilial juvenile muscular atrophy simulating muscular dystrophy. AMA Arch Neurol Psychiatry. 1956 May;75(5):500–509. doi: 10.1001/archneurpsyc.1956.02330230050005. [DOI] [PubMed] [Google Scholar]
  13. Kondo K. Beitrag zur "pseudo-dystrophischen" Natur der Amyotrophie bei der Wohlfart-Kugelberg-Welanderschen Krankheit. Acta Neuropathol. 1969;13(1):29–42. doi: 10.1007/BF00686139. [DOI] [PubMed] [Google Scholar]
  14. Mc Comas A. J., Sica R. E., Currie S. Muscular dystrophy: evidence for a neural factor. Nature. 1970 Jun 27;226(5252):1263–1264. doi: 10.1038/2261263a0. [DOI] [PubMed] [Google Scholar]
  15. McComas A. J., Mrozek K. Denervated muscle fibres in hereditary mouse dystrophy. J Neurol Neurosurg Psychiatry. 1967 Dec;30(6):526–530. doi: 10.1136/jnnp.30.6.526. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. McComas A. J., Sica R. E., Campbell M. J. "Sick" motoneurones. A unifying concept of muscle disease. Lancet. 1971 Feb 13;1(7694):321–326. doi: 10.1016/s0140-6736(71)91045-2. [DOI] [PubMed] [Google Scholar]
  17. Milhorat A. T., Shafiq S. A., Goldstone L. Changes in muscle structure in dystrophic patients, carriers and normal siblings seen by electron microscopy; correlation with levels of serum creatinephosphokinase (CPK). Ann N Y Acad Sci. 1966 Sep 9;138(1):246–292. doi: 10.1111/j.1749-6632.1966.tb41170.x. [DOI] [PubMed] [Google Scholar]
  18. Patel A. N., Razzak Z. A., Dastur D. K. Disuse atrophy of human skeletal muscles. Arch Neurol. 1969 Apr;20(4):413–421. doi: 10.1001/archneur.1969.00480100089013. [DOI] [PubMed] [Google Scholar]
  19. Rosman N. P., Kakulas B. A. Mental deficiency associated with muscular dystrophy. A neuropathological study. Brain. 1966 Dec;89(4):769–788. doi: 10.1093/brain/89.4.769. [DOI] [PubMed] [Google Scholar]
  20. Shafiq S. A., Milhorat A. T., Gorycki M. A. Fine structure of human muscle in neurogenic atrophy. Neurology. 1967 Oct;17(10):934–948. doi: 10.1212/wnl.17.10.934. [DOI] [PubMed] [Google Scholar]
  21. TAKEUCHI T. Histochemical demonstration of branching enzyme (amylo-1,4-1,6-transglucosidase) in animal tissues. J Histochem Cytochem. 1958 May;6(3):208–216. doi: 10.1177/6.3.208. [DOI] [PubMed] [Google Scholar]
  22. Zellweger H., Hanson J. W. Psychometric studies in muscular dystrophy type 3a (Duchenne). Dev Med Child Neurol. 1967 Oct;9(5):576–581. doi: 10.1111/j.1469-8749.1967.tb02327.x. [DOI] [PubMed] [Google Scholar]
  23. Zellweger H., Niedermeyer E. Central nervous system manifestations in childhood muscular dystrophy (CMD). I. Psychometric and electroencephalographic findings. Ann Paediatr. 1965;205(1):25–42. [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES